Ambrisentan for Early-Stage Low-Risk Pulmonary Arterial Hypertension: Design of the Randomized, Double-Blind, Placebo-Controlled ALEPH Trial | JACC Asia
Jun 2, 2026
0:30
Episode Description
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
